Tilray Medical, a division of Tilray Brands (TSX:TLRY), has become the first company to receive Italian authorization to distribute medical cannabis flower for therapeutic use Tilray is a global ...

MONTRÉAL, June 23, 2025 (GLOBE NEWSWIRE) -- TC Transcontinental (TSX: TCL.A TCL.B) announced today the acquisition of Middleton Group, a provider of retail services and point-of-purchase display ...

Cymat Technologies (TSXV:CYM) signed a letter of intent with Rio Tinto Alcan to acquire the latter’s aluminum metal matrix composite technology, including an existing customer base ...

On March 5, the Company announced closing of a non-brokered private placement by issuing a total of 11,799,700 units at a price of $0.05CDN per Unit, for total gross proceeds $589,985CDN. Each unit ...

Kyushu’s First-ever LNG Procurement Contract from the U.S. Energy Transfer LP (NYSE: ET) today announced its subsidiary, Energy Transfer LNG Export, LLC (Energy Transfer LNG), has entered into a ...

VANCOUVER, BC / ACCESS Newswire / May 9, 2025 / Storm Exploration Inc. (TSXV:STRM) ("Storm" or the "Company") announced today that, further to its news release dated May 23, 2024, it has amended its ...

SAN FRANCISCO, June 10, 2025 /PRNewswire/ -- Instacart (Nasdaq: CART), the leading grocery technology company in North America, today announced an expanded partnership with The Trade Desk (Nasdaq: TTD ...

TORONTO, June 18, 2025 /CNW/ - Evolve Funds Group Inc. ("Evolve") is pleased to announce the distribution amounts per unit (the "Distributions") for certain funds (the "Evolve Funds"), as indicated in ...

CALHOUN, Georgia, May 01, 2025 (GLOBE NEWSWIRE) -- Mohawk Industries, Inc. (NYSE: MHK) today announced first quarter 2025 net earnings of $73 million and earnings per share (“EPS”) of $1.15; adjusted ...

Mr. Dale Andres has been appointed Chief Executive Officer and Director of the Company, effective June 23, 2025. Mr. Andres has been a non-executive director of the Company since May 9, 2023. Mr.

CALGARY, AB / ACCESS Newswire / May 20, 2025 / Touchstone Exploration Inc. ("Touchstone" or the "Company") (TSX:TXP) (LSE:TXP) is pleased to announce that it successfully closed the previously ...

Company remains on track to submit NDA for bitopertin in erythropoietic protoporphyria (EPP) in H2 2025 Initiated APOLLO, a confirmatory clinical trial of bitopertin in adults and adolescents with EPP ...